NDC 53225-2001-01 - Prolaxa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53225-2001
- Requested NDC
- 53225-2001-01
- Package NDCs from labels
- 53225-2001-1, 53225-2001-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2025-08-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Prolaxa - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2025-08-05 | HUMAN OTC DRUG LABEL |
| Prolaxa - Terrain Pharmaceuticals | Terrain Pharmaceuticals | 2025-06-12 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53225-2001-1 | Prolaxa | 100 in 1 BOTTLE, PLASTIC | CAPSULE, LIQUID FILLED | 100 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53225-2001 | PROLAXA (DOCUSATE SODIUM 250MG) CAPSULE, LIQUID FILLED [TERRAIN PHARMACEUTICALS] | 1 | Current NDC, 1 package rows | 20250416_32610e42-f352-09fd-e063-6394a90abff6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 53225-2001-1 | EA - Each | 53225-2001 | aa1310eb-6faa-4bfc-a75f-85befacab3b4 | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fleet | GLYCERIN | C.B. Fleet Company, Inc. | 31778652-e60e-4098-8e90-3e4f56b5800c | 2026-03-06 | Warnings | M007 PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 4c6094b7-c1ef-26a3-e063-6394a90af4cc | 2026-03-06 | Warnings | M007 PDC6A3C0OX |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | PDC6A3C0OX |
| Stool Softener plus Stimulant Laxative | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | CARDINAL HEALTH, 110 DBA LEADER | 3fd9ba76-42f8-4ebe-b1bc-f81f08e702ce | 2026-03-06 | Warnings | M007 F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM 100MG | Pharbest Pharmaceuticals, Inc. | 025e03e0-e273-47ed-87f7-98e388abe047 | 2026-03-05 | Warnings | F05Q2T2JA0 |
| Dry Eye Relief Sterile Lubricant Eye Drops | GLYCERIN | Similasan Corporation | 4c4cce1c-392e-354d-e063-6294a90a0ca3 | 2026-03-05 | Warnings | PDC6A3C0OX |
| Magnesium Citrate | EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON | Walmart Inc. | 484d0421-59ea-3783-e063-6394a90af633 | 2026-03-04 | Warnings | M007 |
| Magnesium Citrate | EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | Walmart Inc. | 484c2586-9e6f-1ce5-e063-6394a90a0d81 | 2026-03-04 | Warnings | M007 |
| Magnesium Citrate | EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE | Walmart Inc. | 450ddcbd-7ccd-3670-e063-6294a90ac2bd | 2026-03-04 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Amazon.com Services LLC | 787ec4b0-c6c5-44ab-a53d-d6d25304f95e | 2026-03-03 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 3d0d63d7-640d-4e54-a6fd-6b265c79be09 | 2026-03-02 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 9b3b6cea-ab83-4b7c-a425-fd0ac7df426c | 2026-03-02 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 51ed515b-cc51-4ea1-b612-090476135005 | 2026-03-02 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Old East Main Co. | a8af6e2d-0052-4fc9-a51a-c9dbeb1ad3f5 | 2026-03-02 | Warnings, Adverse reactions | M007 |
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| citroma | MAGNESIUM CITRATE | Chain Drug Marketing Association | 629c5817-13b7-4527-8998-93131ee3529e | 2026-02-27 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Chain Drug Marketing Association | 4df97cdc-e7a2-4350-8f95-a679cdcaff64 | 2026-02-27 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Chain Drug Marketing Association | 46b26b44-e065-4337-a071-fa036f897140 | 2026-02-27 | Warnings, Adverse reactions | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE | Chain Drug Marketing Association | ef163b24-ce92-4cbc-b45a-4fae3b511949 | 2026-02-27 | Warnings, Adverse reactions | M007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.